New patent for Allergan drug RESTASIS MULTIDOSE

Annual Drug Patent Expirations for RESTASIS+MULTIDOSE Restasis Multidose is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are ten patents…

The post New patent for Allergan drug RESTASIS MULTIDOSE appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog